Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Other Non-Current Liabilities (2022 - 2023)

Historic Other Non-Current Liabilities for Therapeutics (LENZ) over the last 2 years, with Q1 2023 value amounting to $871000.0.

  • Therapeutics' Other Non-Current Liabilities changed N/A to $871000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $871000.0, marking a year-over-year change of. This contributed to the annual value of $10.8 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Therapeutics reported Other Non-Current Liabilities of $871000.0 as of Q1 2023.
  • Over the past 5 years, Therapeutics' Other Non-Current Liabilities peaked at $10.8 million during Q4 2022, and registered a low of $871000.0 during Q1 2023.